News

Our company mission - to improve people’s lives - is reflected both inside and outside the company.

Our consumers and our employees are at the heart of every decision we make, whether a small day-to-day matter or a large-scale corporate strategy.

We believe that food has the power to bring people together, not tear them apart. That’s why we use the highest quality grains and gluten-free ingredients to make products that are safe, nutritionally balanced, and also taste good.

2023 was a more than successful year, enabling us to consolidate our leadership in the gluten-free sector.

Under the leadership of Hannes Berger, CEO of Dr. Schär, we ended the 2023 financial year on a positive note with global sales of €561 million (+16,8% compared to 2022), confirming the growth trend for both domestic and international markets.  This is an accomplishment achieved also focusing on the local productions. This not only makes it easier for us to source our products and meet our customers’ needs in a timely manner, but also limits our CO2 emissions.

We are seeding a better world, one pack at a time. Packaging plays a fundamental role in our path to a greener, more sustainable world. Which is why we’re trying to reduce our use of plastic. 

In the food industry, plastic has proven to be a very effective packaging material as it guarantees the freshness, conservation, and safety of food, especially when it comes to specific products like gluten-free items. However, we are well aware that plastic causes significant damage to the environment and, when disposed of improperly, it can have an even greater negative impact. Balancing the sustainability, safety and proper conservation of our products is a challenge that we have embraced, to make all packaging for the 200+ different products sold globally under the Schär brand recycled, recyclable and compostable, without compromising our quality standards.

A varied and balanced diet plays a crucial role in maintaining a healthy lifestyle. However, for some people suffering from chronic conditions, diet is not just a good practice but a key aspect an integral part of their treatment. A gluten-free diet is currently the only treatment available for people with coeliac disease or gluten-related conditions. A low-protein diet can be a valuable ally in reducing the progression of chronic renal failure. Numerous studies have confirmed the value of the ketogenic diet in cases of fat malabsorption and maldigestion and in the treatment of neurological disorders. One in four adults suffers from metabolic syndrome, in which a correct and balanced diet is an ally in preventing a deterioration in health.

At Dr. Schär we strive to maintain an exemplary compliance culture and to optimize it continuously. For this reason, we have been operating a whistleblowing system for several years, drawing attention to possible abuse and misconduct cases. As of 15 July, the email address to contact is: whistleblowing@drschaer.com.

“I believe we have a moral duty to protect the planet for future generations: our children and grandchildren - this is the profound conviction of Ulrich Ladurner - Chairman of Dr. Schär - which guides the strategies and projects pursued by all of us at Dr. Schär”.

Biodiversity is one of the most precious resources on Earth. We are committed to preserving it by promoting a sustainable agriculture and an ‘accompanied’ supply chain free of negative impacts on forests, but also by implementing research projects aimed at the recovery of minor crops such as sorghum, buckwheat, and millet. A concrete example of this approach is VItaMi - Varietà Italiane di Miglio - a project that aims to select new millet varieties adapted to European soil and climatic conditions, that will be grown by partner farmers to produce the Schär products of the future.

The prevalence of coeliac disease is estimated to be on the rise, but the number of diagnoses remains too low.

Coeliac disease, the most common autoimmune disease in children, which primarily involves the intestine and the immune system, has an overall prevalence of 1% [1]. An estimated figure, however, that does not take either wide local variations or undiagnosed cases into account. Sweden and Finland, for example, but also certain geographically localised populations of India and North Africa are among the countries with a higher prevalence. In Asia, the condition is extremely rare and the causes are still unknown, although they may be related to the eating habits of that area.

Gluten-free products are a matter of trust. They need to be safe because they represent the only treatment for those suffering from gluten-related disorders. They also need to be tasty because mealtimes should not be unpleasant experiences.